Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-009052

Options or other derivatives

  • Exec. VP Chief Legal Officer acquired 13,090 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stark David Matthew · Exec. VP Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-11 Grant or award : show line 1 in the form Restricted Share Units +13,090 13,090 D
Loading xslF345X03/doc4.xml…